- Nanotechnology developer Sixth Wave Innovations (SIXW) has received C$250,000 in funding from the Nova Scotia COVID-19 Response Council
- The contribution is for development of the company’s AMIPs technology, which will rapidly detect viruses in the air
- Under a recent agreement, Sixth Wave will continue developing its AMIPs, for the purpose of binding to the COVID-19 virus
- This project is subject to the company’s current collaboration with York University and the Centre Technologique des Residus Industriels
- Sixth Wave Innovations (SIXW) is up 8.33 per cent and is trading at $0.32 per share
Nanotechnology developer Sixth Wave Innovations (SIXW) has received C$250,000 in funding from the Nova Scotia COVID-19 Response Council.
The NSCRC has provided this contribution for the development of the company’s AMIPs technology. AMIPs (Accelerated Molecularly Imprinted Polymers) are used to extract and detect targeted substances at the molecular level.
In this case, Sixth Wave is trying to develop AMIPs which will rapidly detect viruses like COVID-19 in the air. Under the terms of a recent agreement, the company will develop an AMIP specifically for the purpose of selectively binding to the SARS-CoV-2.
If successful, this could be extrapolated to the rapid delivery of a visual and/or electronic response once the virus is detected and verified. The technology could have applications in various rapid detection products, including test kits, SmartMasks, and air and water monitoring systems.
However, development of the air monitoring technology is subject to Sixth Wave’s previously announced collaboration from June of this year. The company formed a partnership with York University and the Centre Technologique des Residus Industriels, in order to develop the AMIPs virus detection technology.
Sixth Wave’s CEO, Dr Jon Gluckman, expressed the company’s appreciation to the Province of Nova Scotia for its participation in the project.
“Sixth Wave has a substantial history of delivering similarly complex MIP-based solutions within limited timelines, as evidenced by our explosives detection wipes and bacterial pathogen diagnostic tools.
“We welcome this opportunity to once again prove the utility of molecular imprinting as a detection and diagnostic tool, especially in circumstances of such importance to public health and security,” he said.
Sixth Wave Innovations (SIXW) is up 8.33 per cent and is trading at $0.32 per share at 11:05am EDT.
